CWP
REGN icon

Cyndeo Wealth Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Cyndeo Wealth Partners’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$421K Hold
676
– – 0.02% 372
2026
Q1 		$522K Sell
676
-4
-0.6% -$3.06K 0.03% 317
2025
Q4 		$525K Buy
680
+3
+0.4% +$2.04K 0.03% 313
2025
Q3 		$380K Buy
677
+1
+0.1% +$565 0.02% 349
2025
Q2 		$355K Sell
676
-1
-0.1% -$558 0.02% 355
2025
Q1 		$429K Sell
677
-71
-9% -$48.8K 0.03% 319
2024
Q4 		$533K Sell
748
-1
-0.1% -$839 0.04% 288
2024
Q3 		$787K Sell
749
-199
-21% -$221K 0.06% 244
2024
Q2 		$996K Buy
948
+109
+13% +$106K 0.08% 212
2024
Q1 		$808K Hold
839
– – 0.07% 221
2023
Q4 		$737K Buy
839
+3
+0.4% +$2.47K 0.07% 215
2023
Q3 		$688K Buy
836
+90
+12% +$70.7K 0.07% 199
2023
Q2 		$536K Sell
746
-2
-0.3% -$1.54K 0.06% 214
2023
Q1 		$615K Sell
748
-5
-0.7% -$3.77K 0.07% 199
2022
Q4 		$543K Buy
+753
New +$556K 0.06% 208

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
HCM
Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Cyndeo Wealth Partners's REGN Position: Q2 2026 in Review

Cyndeo Wealth Partners held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 676 shares worth $421K. The position accounts for 0.02% of the portfolio, ranked #372.

Cyndeo Wealth Partners first reported a position in REGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $996K in Q2 2024. 237 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Cyndeo Wealth Partners held 676 shares of Regeneron Pharmaceuticals worth $421K as of Q2 2026.
  • Cyndeo Wealth Partners left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.02% of Cyndeo Wealth Partners's portfolio in Q2 2026, its #372 holding.
  • Cyndeo Wealth Partners first reported a position in Regeneron Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
  • Cyndeo Wealth Partners's Regeneron Pharmaceuticals position peaked at $996K in Q2 2024.
  • 237 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Cyndeo Wealth Partners's 13F filing for Q2 2026, filed 21 Jul 2026.